Serum uric acid as an independent predictor of recurrence in ischemic stroke patients
International Clinical Neuroscience Journal,
Vol. 2 No. 3 (2015),
30 December 2015
,
Page 101-104
https://doi.org/10.22037/icnj.v2i3.10946
Abstract
Background and Purpose: The relationship between uric acid and stroke recurrence is ambiguous. Some studies have explored this relationship in acute ischemic stroke but had different results. We evaluated the association of admission uric acid level with risk of stroke recurrence in patients with ischemic stroke.
Methods: We studied ischemic stroke patients presenting to our hospital with Magnetic Resonance Imaging-confirmed acute ischemic stroke. Blood samples were drawn within 24 h of admission for uric acid concentration. Information on age, prior hypertension, hyperlipidemia, diabetes, ischemic heart disease, and smoking status was collected. We assessed the relationship between uric acid level and stroke recurrence at 90 days after stroke onset.
Results: Two hundred patients were studied. Twenty-seven patients suffered from a recurrence event. Hyperuricemia was found in 48 (24%) patients. Mean serum uric acid level in patients with recurrence was 6.6±1.3 and in patients without recurrence was 5.2±1.5 mg/dl. On multiple logistic regression analysis, the independent relationship between higher uric acid level levels and recurrence was confirmed (odds ratio, 1.29; 95% confidence interval, 1.12-1.73; p=0.01).
Conclusion: Elevated uric acid concentration is significantly and independently associated with increased risk of stroke recurrence in ischemic stroke patients.- Uric acid
- Stroke
- Recurrence
How to Cite
References
Li R, Huang C, Chen J, Guo Y, Tan S. The role of uric acid as a potential neuroprotectant in acute ischemic stroke: a review of literature. Neurol Sci. 2015:36(7):1097-103.
Storhaug HM, Norvik JV, Eriksen BO, Løchen ML, Zykova S, et al. Uric acid is a risk factor for ischemic stroke and all-cause mortality in the general population: a gender specific analysis from The Tromsø Study. BMC Cardiovasc Disord. 2013:11;13:115.
Weir CJ, Muir SW, Walters MR, Lees KR. Serum Urate as an independent predictor of poor outcome and future vascular events after acute ischemic stroke. Stroke. 2003:34(8);1951-1956
Kim SY, Guevara JP, Kim KM, Choi HK, Heitjan DF, Albert DA. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009 Jul 5;61(7):885-92.
Llull L, Laredo C, Renú A, Pérez B, Vila E, Obach V, et al. Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke. Stroke. 2015 Aug;46(8):2162-7.
Wang Z, Lin Y, Liu Y, Chen Y, Wang B, Li C, et al. Serum Uric Acid Levels and Outcomes After Acute Ischemic Stroke. Mol Neurobiol. 2015 Mar 7.
Iranmanesh F, Sheykholeslami NZ, Gadari F, Ahmady J. Acute ischemic non-embolic stroke and serum level of uric acid. Iran J Neurol. 2012;11(1):1-5.
Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417734 men and women in the Apolipoprotein Mortality RISK study (AMORIS). J Intern Med 2009;266(6):558-570.
Huang J, Hu D, Wang Y, Zhang D, Qu Y. Dose-response relationship of serum uric acid levels with risk of stroke mortality. Atherosclerosis. 2014;234(1):1-3.
Mayer FJ, Mannhalter C, Minar E, Schillinger M, Chavakis T, Siegert G, et al. The impact of uric acid on long-term mortality in patients with asymptomatic carotid atherosclerotic disease. J Stroke Cerebrovasc Dis. 2015;24(2):354-61.
Mehrpour M, Khuzan M, Najimi N, Motamed MR, Fereshtehnejad SM. Serum uric acid level in acute stroke patients. Med J Islam Repub Iran. 2012;26(2):66-72.
Newman EJ, Rahman FS, Lees KR, Weir CJ, Walters MR. Elevated serum urate concentration independently predicts poor outcome following stroke in patients with diabetes. Diabetes Metab Res Rev. 2006; 22(1):79-82.
Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis. 2010; 209(1):215-9.
Khalil MI, Islam MJ, Ullah MA, Khan RK, Munira S, Haque MA, et al. Association of serum uric acid with ischemic stroke. Mymensingh Med J. 2013; 22(2):325-30.
Wu H, Jia Q, Liu G, Liu L, Pu Y, Zhao X, et al. Decreased uric acid levels correlate with poor outcomes in acute ischemic stroke patients, but not in cerebral hemorrhage patients. J Stroke Cerebrovasc Dis. 2014 Mar;23(3):469-75.
Higgins P, Walters MR, Murray HM, McArthur K, McConnachie A, Lees KR. Allopurinol reduces brachial and central blood pressure and carotid intima-media thickness progression after ischaemic stroke and transient ischaemic attack: a randomised controlled trial. Heart. 2014 ;100(14):1085-92.
Amaro S, Urra X, Gomez-Choco M, Obach V, Cervera A, Vargas M, et al. Uric acid levels are relevant in patients with stroke treated with thrombolysis. Stroke. 2011;13:S28–S32.
Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol. 2005;13:3553–3562.
Chamorro A, Amaro S, Castellanos M, Segura T, Arenillas J, Martí-Fábregas J, et al. Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): a randomised, double-blind phase 2b/3 trial. Lancet Neurol. 2014;13(5):453-60.
Kanellis J, Watanabe S, Li JH, Kang DH, Li P, Nakagawa T, et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension. 2003 Jun;41(6):1287-93.
Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, et al. Investigation into the sources of superoxide in human blood vessels: Angiotensin II increases superoxide production in human internal mammary arteries. Circulation. 2000:9;101(18):2206-12.
- Abstract Viewed: 963 times
- PDF Downloaded: 768 times